Our latest news
Le cancer colorectal, souvent appelé cancer du côlon, est la deuxième cause mondiale de décès dû au cancer et la troisième...
Forget Vampires… Garlic could Kill Cancer!
Prof. Marc Diederich and a team of researchers spotted around the world have discovered how a molecule found in garlic can stop cellular growth in colorectal cancer.
Colorectal cancer, or bowel cancer as it is more commonly known, is the second leading cause of cancer-related deaths worldwi...
[Video] Personalizing Cancer Treatment Means Crippling Cancer Cells More Efficiently
LBMCC Videos Series - Ep #3
In the third video of this series, Marc Diederich, Associate Professor at SNU, explains what personalized cancer treatment is...
Une nouvelle molécule, un nouvel espoir contre les tumeurs du cerveau
Un nouveau composé chimique, créé grâce à une collaboration menée par le Pr. Marc Diederich, pourrait attaquer les cellules cancéreuses dans le cerveau, montrent des résultats encourageants.
Des nouvelles données suggèrent qu'une personne sur deux pourrait développer une forme de cancer au cours de sa vie, et bi...
A new synthetic treatment against brain tumors may be just around the corner
Another collaboration led by Prof. Marc Diederich offers promising results as the team identify a new man-made compound capable of attacking brain tumor cells.
New data suggests that as many as one in two of us will suffer from cancer at some point in our lives and whilst treatment is...
[Video] Epigenetics and Cancer: Reprogramming the Master Regulator
LBMCC Videos Series - Ep #2
In the second video of this series, Marc Diederich, Associate Professor at SNU, explains master regulators, natural regulato...
Des composés naturels pour développer des traitements personnalisés contre le cancer : Retour sur une année 2016 riche en découvertes avec le Pr. Diederich
Au cours de l’année 2016, les chercheurs du LBMCC et du SNU ont identifié un éventail de composés d’origine naturelle ca...
Personalized cancer treatments using naturally-occurring molecules: 2016 research highlights with Prof. Marc Diederich
Over the past year, researchers at the LBMCC and SNU have identified a range of naturally-occurring compounds capable of targ...
Synergie entre deux médicaments contre la leucémie myéloïde aigüe: à un pas d’un traitement efficace
En combinant deux thérapies disponibles dans le commerce, les chercheurs du LBMCC/SNU ont observé une amélioration spec...
Related Publication
Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic...
Published in Leukemia
Author
Drug synergy: one step closer to effective treatment of acute myeloid leukemia
By combing two pre-existing therapies, researchers at the LBMCC/SNU dramatically increased their efficiency against leukemia...
Related Publication
Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic...
Published in Leukemia
Author
- « Previous
- 1
- 2
- 3
- 4
- Next »